Posted: 2024-06-11

The urologic sciences campaign organized by VGH & UBC Hospital Foundation has achieved remarkable success, raising an impressive amount of over $65 million. These funds will be utilized to enhance the quality of care provided to patients in British Columbia, focusing on various areas such as prostate cancer, kidney and bladder cancer, kidney stones, bladder and pelvic health, kidney transplant, sexual and reproductive health, and adolescent transitional urology.

Dr. Gleave
Posted: 2024-05-06

The annual meeting of the American Urological Association (AUA) in San Antonio, TX in 2024, which was hosted by the Society of Urologic Oncology (SUO). Dr. Martin Gleave was honored with the opportunity to deliver the Whitmore lecture during this year's SUO session at AUA. The main focus of his presentation was on optimizing outcomes in high-risk localized prostate cancer – Cure is Possible when Cure is Necessary.

Posted: 2024-04-12

Dr Kishor Wasan, has been awarded the Outstanding Reviewer recognition for their exceptional contribution to peer review. The Review Quality Assurance (RQA) process of CIHR acknowledges outstanding reviewers based on feedback and observations from Committee Chairs, Scientific Officers, and CIHR staff. These contributions include surpassing expectations in reviews, volunteering for additional tasks at short notice, and actively participating in discussions on applications, even those not assigned to them.

Posted: 2024-04-12

Dr. Shaghayegh Nouruzi, a post-doctoral fellow in Dr. Zoubeidi's lab, has been honored with the prestigious Early Investigator Research Award from the US Department of Defense, receiving a total of $400,000 USD in funding. This award will support Dr. Nouruzi's research focusing on understanding the interplay between epigenetic remodeling and metabolomic rewiring during the transition of castration-resistant prostate cancer to treatment-induced neuroendocrine. This recognition underscores the significance and potential impact of Dr.

Posted: 2024-04-08

Our Vancouver Prostate Centre team has successfully raised $70,379 for cancer research and achieved the impressive ranking of #6 on the Top Terry Fox Run Fundraising Teams list in Canada. As a result of these efforts, 2023 marked a record-breaking year for team fundraising, with a total of $5.2 million raised for innovative cancer research.

Posted: 2024-03-26

Ziwei Cai, Sarina Saffarian, and Joslia Jose, who are students from Dr Syam Somasekharan's laboratory, were honored with the prestigious travel awards from the Canadian Institutes of Health Research (CIHR) through the Institute Community Support (ICS) Program. It is worth noting that this award is highly competitive and limited, making it rare for three students from the same lab to receive it. This remarkable achievement showcases the exceptional teamwork of Somasekharan laboratory. Congratulations to all!

Posted: 2024-03-25

This publication outlines the utilization of long-pulsed laser light to treat tumors that have been pre-treated with light-absorbing nano-particles in the far-red spectrum. By exposing the nano-particles to the laser light, the energy is converted to heat, effectively destroying the tumor cells internally. The advantage of using far-red laser light is that it can penetrate deep into tissues without causing harm to healthy tissues. The energy conversion and heating only occur when the light interacts with the nano-particles accumulated in the tumor.

Posted: 2024-02-21

Dr. Syam Somasekharan has been honored with the Idea Development Award - Established Investigator Award in Urologic Sciences by the US Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) for his exceptional work in identifying biomarkers and therapeutic targets for prostate cancer. We would like to congratulate Dr. Somasekharan on securing $1.12 million USD in funding for his research in Urologic Sciences.

Dr. Cherkasov
Posted: 2024-01-18

Dr Artem Cherkasov's success in winning the worldwide drug discovery challenge is praiseworthy. The competition in Conscience's CACHE Challenge series, showcases the triumph of open science and collaborative efforts, which differ from the traditional patent-focused approach where scientists operate independently from rival laboratories. Additionally, the rise of AI as a promising asset in drug discovery is a reason to rejoice.

Posted: 2024-01-04

De novo metastatic prostate cancer is a highly lethal form of cancer that affects men. It is characterized by the sudden onset and severity of aggressive cancer lesions in various parts of the body. Approximately 5 to 10 percent of prostate cancer patients are diagnosed with this condition initially. Dr. Alexander Wyatt, a researcher at Vancouver Prostate Centre, has conducted a groundbreaking study that suggests the complexity of cancer within the prostate may play a significant role in tumor growth in this patient population.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Terry Fox Run fundraiser: September 19th, 2023

The 43nd Annual Terry Fox Run is taking place on Sunday September 19, 2023. If you are able, please consider joining and/or donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research

Pars for Prostate fundraiser: September 21, 2023

The Second Annual Pars for Prostate golf fundraiser in support of Prostate Cancer Foundation BC takes place September 21, 2022 at Westwood Plateau Golf Course. Join today to take part in this best ball, shotgun style tournament. Skilled holes, putting contest, draw prizes and more. For information and to register please click here.


Work at the Vancouver Prostate Centre

Thursday, January 18, 2024

Dr Artem Cherkasov receives world-wide challenge in drug discovery

Dr. Cherkasov
Wednesday, February 21, 2024

Dr. Somasekharan has been granted a $1.12 million USD from the DOD Award